207 related articles for article (PubMed ID: 27830907)
1. Family planning, pregnancy and breastfeeding in multiple sclerosis.
Holmøy T; Torkildsen Ø
Tidsskr Nor Laegeforen; 2016 Nov; 136(20):1726-1729. PubMed ID: 27830907
[TBL] [Abstract][Full Text] [Related]
2. [Pregnancy and immunomodulatory therapy in multiple sclerosis patients].
Hoffmann LA; Kümpfel T; Heer I; Hohlfeld R
Nervenarzt; 2006 Jun; 77(6):663-4, 666-8, 670. PubMed ID: 16468069
[TBL] [Abstract][Full Text] [Related]
3. [Family planning in multiple sclerosis: conception, pregnancy, breastfeeding].
Rózsa C
Ideggyogy Sz; 2020 May; 73(05-06):161-169. PubMed ID: 32579305
[TBL] [Abstract][Full Text] [Related]
4. Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.
Amato MP; Portaccio E
CNS Drugs; 2015 Mar; 29(3):207-20. PubMed ID: 25773609
[TBL] [Abstract][Full Text] [Related]
5. Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding.
Ferrero S; Esposito F; Pretta S; Ragni N
Expert Rev Neurother; 2006 Dec; 6(12):1823-31. PubMed ID: 17181429
[TBL] [Abstract][Full Text] [Related]
6. An overview of pregnancy-related issues in patients with multiple sclerosis.
Pozzilli C; Pugliatti M;
Eur J Neurol; 2015 Oct; 22 Suppl 2():34-9. PubMed ID: 26374512
[TBL] [Abstract][Full Text] [Related]
7. Family planning, antenatal and post partum care in multiple sclerosis: a review and update.
Van Der Walt A; Nguyen AL; Jokubaitis V
Med J Aust; 2019 Sep; 211(5):230-236. PubMed ID: 30919466
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy and multiple sclerosis.
Stuart M; Bergstrom L
J Midwifery Womens Health; 2011; 56(1):41-47. PubMed ID: 21323849
[TBL] [Abstract][Full Text] [Related]
9. The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis.
Fragoso YD; Boggild M; Macias-Islas MA; Carra A; Schaerer KD; Aguayo A; de Almeida SM; Alvarenga MP; Alvarenga RM; Alves-Leon SV; Arruda WO; Brooks JB; Comini-Frota ER; Ferreira ML; Finkelsztejn A; Finkelsztejn JM; de Freitas LD; Gallina AS; da Gama PD; Georgetto S; Giacomo MC; Gomes S; Gonçalves MV; Grzesiuk AK; Kaimen-Maciel DR; Lopes J; Lourenco GA; Malfetano FR; Morales NM; Morales Rde R; Oliveira CL; Onaha P; Patroclo C; Ribeiro SB; Ribeiro TA; Salminen HJ; Santoro P; Seefeld M; Soares PV; Tarulla A; Vasconcelos CC
Clin Neurol Neurosurg; 2013 Feb; 115(2):154-9. PubMed ID: 22633835
[TBL] [Abstract][Full Text] [Related]
10. Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Langer-Gould A; Beaber BE
Clin Immunol; 2013 Nov; 149(2):244-50. PubMed ID: 23434027
[TBL] [Abstract][Full Text] [Related]
11. [Cases of pregnancy in patients with aggressive multiple sclerosis treated with natalizumab].
Yakushina TI; Belova YA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(2. Vyp. 2):94-97. PubMed ID: 31156247
[TBL] [Abstract][Full Text] [Related]
12. [Outcomes of childbearing and pregnancy in women with multiple sclerosis--a literature review].
Vanya M
Orv Hetil; 2015 Aug; 156(34):1360-5. PubMed ID: 26278481
[TBL] [Abstract][Full Text] [Related]
13. Reproductive issues and multiple sclerosis: 20 questions.
Carlson AK; Ontaneda D; Rensel MR; Cohen JA; Kunchok A
Cleve Clin J Med; 2023 Apr; 90(4):235-243. PubMed ID: 37011959
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis and pregnancy.
Bodiguel E; Bensa C; Brassat D; Laplaud D; Le Page E; Ouallet JC; Zephir H; De Seze J;
Rev Neurol (Paris); 2014 Apr; 170(4):247-65. PubMed ID: 24684929
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis and family planning.
Hellwig K
Neurodegener Dis Manag; 2015; 5(6 Suppl):39-42. PubMed ID: 26611271
[No Abstract] [Full Text] [Related]
16. Vaccinations in patients with multiple sclerosis: review and recommendations.
Nesbitt C; Rath L; Zhong M; Cheng AC; Butzkueven H; Wesselingh R; Skibina O; Monif M; Yeh W; Brotherton JM; Reddel S; Van Der Walt A
Med J Aust; 2021 May; 214(8):350-354.e1. PubMed ID: 33866556
[No Abstract] [Full Text] [Related]
17. Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Cuello JP; Martínez Ginés ML; Martin Barriga ML; de Andrés C
Neurologia; 2017 Mar; 32(2):92-98. PubMed ID: 25728948
[TBL] [Abstract][Full Text] [Related]
18. Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).
Fernandez O; Tintore M; Saiz A; Calles-Hernandez MC; Comabella M; Ramio-Torrenta L; Oterino A; Izquierdo G; Tellez N; Garcia-Merino JA; Brieva L; Arnal-Garcia C; Aladro Y; Mendibe-Bilbao MM; Meca-Lallana JE; Romero-Pinel L; Martinez-Gines ML; Arroyo R; Oreja-Guevara C; Costa-Frossard L; Carrascal P; Rodriguez-Antiguedad A
Rev Neurol; 2019 Jun; 68(11):468-479. PubMed ID: 31132136
[TBL] [Abstract][Full Text] [Related]
19. Family planning is the second most relevant factor for treatment decisions after disease activity - No.
Oreja-Guevara C
Mult Scler; 2020 May; 26(6):642-643. PubMed ID: 32081082
[No Abstract] [Full Text] [Related]
20. Family planning is the second most relevant factor for treatment decisions after disease activity - Yes.
Alroughani R
Mult Scler; 2020 May; 26(6):640-641. PubMed ID: 32081078
[No Abstract] [Full Text] [Related]
[Next] [New Search]
